|
1
|
Maeda T, Hobbs RM, Merghoub T, Guernah I,
Zelent A, Cordon-Cardo C, Teruya-Feldstein J and Pandolfi PP: Role
of the proto-oncogene Pokemon in cellular transformation and ARF
repression. Nature. 433:278–285. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Apostolopoulou K, Pateras IS, Evangelou K,
Tsantoulis PK, Liontos M, Kittas C, Tiniakos DG, Kotsinas A,
Cordon-Cardo C and Gorgoulis VG: Gene amplification is a relatively
frequent event leading to ZBTB7A (Pokemon) overexpression in
non-small cell lung cancer. J Pathol. 213:294–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang L, Siu MK, Wong OG, Tam KF, Lam EW,
Ngan HY, Le XF, Wong ES, Chan HY and Cheung AN: Overexpression of
proto-oncogene FBI-1 activates membrane type 1-matrix
metalloproteinase in association with adverse outcome in ovarian
cancers. Mol Cancer. 9:3182010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maeda T, Merghoub T, Hobbs RM, Dong L,
Maeda M, Zakrzewski J, van den Brink MR, Zelent A, Shigematsu H,
Akashi K, et al: Regulation of B versus T lymphoid lineage fate
decision by the proto-oncogene LRF. Science. 316:860–866. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rovin RA and Winn R: Pokemon expression in
malignant glioma: An application of bioinformatics methods.
Neurosurg Focus. 19:E82005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang G, Lunardi A, Zhang J, Chen Z, Ala U,
Webster KA, Tay Y, Gonzalez-Billalabeitia E, Egia A, Shaffer DR, et
al: Zbtb7a suppresses prostate cancer through repression of a
Sox9-dependent pathway for cellular senescence bypass and tumor
invasion. Nat Genet. 45:739–746. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu XS, Genet MD, Haines JE, Mehanna EK,
Wu S, Chen HI, Chen Y, Qureshi AA, Han J, Chen X, et al: ZBTB7A
suppresses melanoma metastasis by transcriptionally repressing
MCAM. Mol Cancer Res. 13:1206–1017. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aggarwal A, Hunter WJ III, Aggarwal H,
Silva ED, Davey MS, Murphy RF and Agrawal DK: Expression of
leukemia/lymphoma-related factor (LRF/POKEMON) in human breast
carcinoma and other cancers. Exp Mol Pathol. 89:140–148. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lampropoulos P, Zizi-Sermpetzoglou A,
Rizos S, Kostakis A, Nikiteas N and Papavassiliou AG: Prognostic
significance of transforming growth factor beta (TGF-β) signaling
axis molecules and E-cadherin in colorectal cancer. Tumour Biol.
33:1005–1014. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou L, Lopes JE, Chong MM, Ivanov II, Min
R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, et al:
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by
antagonizing RORgammat function. Nature. 453:236–240. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo S, Kleemann GA, Ashraf JM, Shaw WM and
Murphy CT: TGF-β and insulin signaling regulate reproductive aging
via oocyte and germline quality maintenance. Cell. 143:299–312.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Flanders KC and Wakefield LM: Transforming
growth factor-(beta)s and mammary gland involution; functional
roles and implications for cancer progression. J Mammary Gland Biol
Neoplasia. 14:131–144. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moses H and Barcellos-Hoff MH: TGF-beta
biology in mammary development and breast cancer. Cold Spring Harb
Perspect Biol. 3:a0032772011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Derynck R and Akhurst RJ: Differentiation
plasticity regulated by TGF-beta family proteins in development and
disease. Nat Cell Biol. 9:1000–1004. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johansson J, Tabor V, Wikell A, Jalkanen S
and Fuxe J: TGF-β1-induced epithelial-mesenchymal transition
promotes monocyte/macrophage properties in breast cancer cells.
Front Oncol. 5:32015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lv ZD, Kong B, Li JG, Qu HL, Wang XG, Cao
WH, Liu XY, Wang Y, Yang ZC, Xu HM and Wang HB: Transforming growth
factor-β 1 enhances the invasiveness of breast cancer cells by
inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Oncol Rep. 29:219–225. 2013.PubMed/NCBI
|
|
17
|
Walsh LA and Damjanovski S: IGF-1
increases invasive potential of MCF 7 breast cancer cells and
induces activation of latent TGF-β1 resulting in epithelial to
mesenchymal transition. Cell Commun Signal. 9:102011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Deng B, Yang X, Liu J, He F, Zhu Z and
Zhang C: Focal adhesion kinase mediates TGF-beta1-induced renal
tubular epithelial-to-mesenchymal transition in vitro. Mol Cell
Biochem. 340:21–29. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dhaouadi N, Li JY, Feugier P, Gustin MP,
Dab H, Kacem K, Bricca G and Cerutti C: Computational
identification of potential transcriptional regulators of TGF-β1 in
human atherosclerotic arteries. Genomics. 103:357–370. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li W, Kidiyoor A, Hu Y, Guo C, Liu M, Yao
X, Zhang Y, Peng B and Zheng J: Evaluation of transforming growth
factor-β1 suppress Pokemon/epithelial-mesenchymal transition
expression in human bladder cancer cells. Tumour Biol.
36:1155–1162. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zu X, Yu L, Sun Q, Liu F, Wang J, Xie Z,
Wang Y, Xu W and Jiang Y: SP1 enhances Zbtb7A gene expression via
direct binding to GC box in HePG2 cells. BMC Res Notes. 2:1752009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu Z, Zhong L, Krishack PA, Robbins S,
Cao JX, Zhao Y, Chung S and Cao D: Structure and promoter
characterization of aldo-keto reductase family 1 B10 gene. Gene.
437:39–44. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao C, She T, Wang L, Su Y, Qu L, Gao Y,
Xu S, Cai S and Shou C: Daucosterol inhibits cancer cell
proliferation by inducing autophagy through reactive oxygen
species-dependent manner. Life Sci. 137:37–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhong J, Cao RX, Zu XY, Hong T, Yang J,
Liu L, Xiao XH, Ding WJ, Zhao Q, Liu JH and Wen GB: Identification
and characterization of novel spliced variants of PRMT2 in breast
carcinoma. FEBS J. 279:316–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maeda T, Hobbs RM and Pandolfi PP: The
transcription factor Pokemon: A new key player in cancer
pathogenesis. Cancer Res. 65:8575–8578. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao Y, Yao YH, Li L, An WF, Chen HZ, Sun
LP, Kang HX, Wang S and Hu XR: Pokemon enhances proliferation, cell
cycle progression and anti-apoptosis activity of colorectal cancer
independently of p14ARF-MDM2-p53 pathway. Med Oncol. 31:2882014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sartini D, Lo Muzio L, Morganti S, Pozzi
V, Di Ruscio G, Rocchetti R, Rubini C, Santarelli A and Emanuelli
M: Pokemon proto-oncogene in oral cancer: potential role in the
early phase of tumorigenesis. Oral Dis. 21:462–469. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu XS, Haines JE, Mehanna EK, Genet MD,
Ben-Sahra I, Asara JM, Manning BD and Yuan ZM: ZBTB7A acts as a
tumor suppressor through the transcriptional repression of
glycolysis. Genes Dev. 28:1917–1928. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sanchez-Capelo A: Dual role for TGF-beta1
in apoptosis. Cytokine Growth Factor Rev. 16:15–34. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Duangkumpha K, Techasen A, Loilome W,
Namwat N, Thanan R, Khuntikeo N and Yongvanit P: BMP-7 blocks the
effects of TGF-β-induced EMT in cholangiocarcinoma. Tumour Biol.
35:9667–9676. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kang Y, He W, Tulley S, Gupta GP,
Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL and
Massagué J: Breast cancer bone metastasis mediated by the Smad
tumor suppressor pathway. Proc Natl Acad Sci USA. 102:pp.
13909–13914. 2005; View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bierie B and Moses HL: Tumour
microenvironment: TGFbeta: The molecular Jekyll and Hyde of cancer.
Nat Rev Cancer. 6:506–520. 2006. View
Article : Google Scholar : PubMed/NCBI
|
